These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 745584

  • 41. Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features.
    Nagai MA, Marques LA, Yamamoto L, Fujiyama CT, Brentani MM.
    Int J Cancer; 1994 Nov 01; 59(3):351-6. PubMed ID: 7927940
    [Abstract] [Full Text] [Related]

  • 42. [Steroid hormone receptors in ovarian carcinomas and their clinical significance].
    Geyer H, Teufel G, de Gregorio G, Pfleiderer A.
    Onkologie; 1984 May 01; 7 Suppl 2():44-52. PubMed ID: 6379538
    [Abstract] [Full Text] [Related]

  • 43. Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.
    Alanko A, Heinonen E, Scheinin T, Tolppanen EM, Vihko R.
    Cancer; 1985 Oct 01; 56(7):1696-700. PubMed ID: 4027900
    [Abstract] [Full Text] [Related]

  • 44. Relationship of estrogen and progesterone receptors to prognosis in breast cancer.
    Gelbfish GA, Davidson AL, Kopel S, Schreibman B, Gelbfish JS, Degenshein GA, Herz BL, Cunningham JN.
    Ann Surg; 1988 Jan 01; 207(1):75-9. PubMed ID: 3337566
    [Abstract] [Full Text] [Related]

  • 45. Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand.
    Press MF, Xu SH, Wang JD, Greene GL.
    Am J Pathol; 1989 Nov 01; 135(5):857-64. PubMed ID: 2683797
    [Abstract] [Full Text] [Related]

  • 46. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
    Macías A, Pascual MR, Pérez R, Lage A.
    Neoplasma; 1983 Nov 01; 30(5):593-601. PubMed ID: 6656963
    [Abstract] [Full Text] [Related]

  • 47. Assessment of results of estrogen and progesterone receptor assays performed in a community hospital.
    Szakacs JG, Arroyo JG, Girgenti AJ.
    Ann Clin Lab Sci; 1986 Nov 01; 16(4):266-73. PubMed ID: 3740795
    [Abstract] [Full Text] [Related]

  • 48. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE, Gough M, Middleton K, Hsieh M, Furnas L, Seidl B, Gibbons K, Pyke C, Shannon C, Woodward N, Armes JE.
    J Clin Pathol; 2017 Nov 01; 70(11):954-960. PubMed ID: 28416639
    [Abstract] [Full Text] [Related]

  • 49. Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
    Fernandez MD, Alaghband-Zadeh J, Burn JI.
    Clin Oncol; 1983 Sep 01; 9(3):245-50. PubMed ID: 6616999
    [Abstract] [Full Text] [Related]

  • 50. Steroid hormone receptors in the management of human breast cancer.
    Knight WA, Osborne CK, Yochmowitz MG, McGuire WL.
    Ann Clin Res; 1980 Oct 01; 12(5):202-7. PubMed ID: 7015982
    [Abstract] [Full Text] [Related]

  • 51. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
    Bonomi P, Johnson P, Anderson K, Wolter J, Bunting N, Strauss A, Roseman D, Shorey W, Economou S.
    Semin Oncol; 1985 Mar 01; 12(1 Suppl 1):48-54. PubMed ID: 3975653
    [Abstract] [Full Text] [Related]

  • 52. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.
    J Natl Cancer Inst; 2005 Sep 07; 97(17):1254-61. PubMed ID: 16145046
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers.
    Pichon MF, Broet P, Magdelenat H, Delarue JC, Spyratos F, Basuyau JP, Saez S, Rallet A, Courriere P, Millon R, Asselain B.
    Br J Cancer; 1996 Jun 07; 73(12):1545-51. PubMed ID: 8664127
    [Abstract] [Full Text] [Related]

  • 55. Steroid receptors in breast cancer.
    Desombre ER.
    Monogr Pathol; 1984 Jun 07; (25):149-74. PubMed ID: 6377047
    [Abstract] [Full Text] [Related]

  • 56. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
    Keshgegian AA.
    Arch Pathol Lab Med; 1994 Mar 07; 118(3):240-4. PubMed ID: 8135626
    [Abstract] [Full Text] [Related]

  • 57. Effects of temperature, storage and sodium molybdate on the analysis of estrogen and progesterone receptors in rabbit uterine tissue and gynecologic tumor.
    Leung BS.
    Horm Res; 1984 Mar 07; 19(4):243-52. PubMed ID: 6745845
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.
    Vihko R, Alanko A, Isomaa V, Kauppila A.
    Med Oncol Tumor Pharmacother; 1986 Mar 07; 3(3-4):197-210. PubMed ID: 3543533
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.